awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33415759-7898D16F-5719-4257-98F4-B1C817DA7C8E
Q33415759-7898D16F-5719-4257-98F4-B1C817DA7C8E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415759-7898D16F-5719-4257-98F4-B1C817DA7C8E
Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma.
P921
Q33415759-7898D16F-5719-4257-98F4-B1C817DA7C8E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415759-7898D16F-5719-4257-98F4-B1C817DA7C8E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
68ddfb65eed1b41401e13b216048a025b57932a0
P921
ixazomib citrate